Dye-based chromoendoscopy detects more neoplasia than white light endoscopy in patients with primary sclerosing cholangitis and IBD
Endoscopy International Open · 01.11.2024 · 12 (11) · E1285-E1294
DOI: 10.1055/a-2437-8102 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy International Open, erschienen am 01.11.2024. Verfasst von Rodrigo V Motta und 8 weiteren Autor:innen. Beteiligte Einrichtung: Translational Gastroenterology and Liver Unit, Experimental Medicine Division, Nuffield Department of Medicine, University of Oxford, Oxford, United …. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Wellcome Trust, NIHR Oxford Biomedical Research Centre, Cancer Research UK.
Abstract (Originalsprache)
Background and study aims Patients with primary sclerosing cholangitis and inflammatory bowel disease (IBD) have a high risk of colorectal cancer. There is no agreement on the best technique for surveillance for colorectal neoplasia. We aimed to assess whether chromoendoscopy and/or high-definition endoscopy is associated with increased detection of neoplasia in patients with primary sclerosing cholangitis undergoing surveillance compared with when they were not used. Patients and methods This was a single-center, retrospective, observational study designed to analyze differences in the detection of neoplasia (adenomatous and serrated) among patients with primary sclerosing cholangitis and IBD who underwent annual surveillance between 2010 and 2020. Multilevel logistic regression was used to adjust for confounders.
Results
Ninety-one patients were identified, resulting in 359 colonoscopies with 360 person-years of follow up. Over the study period, 22 of 91 patients (24%) had at least one neoplastic lesion identified; however, the mean neoplastic lesion rate was 0.87 (54/63) for the primary sclerosing cholangitis-ulcerative colitis subgroup compared with 0.24 (4/17) for the primary sclerosing cholangitis-Crohn’s disease subgroup. Chromoendoscopy was associated with a significantly higher detection rate for neoplasia (odds ratio [OR] 5.58, 95% confidence interval [CI] 2.08–14.9,P=0.001), and this association remained after adjusting for confounders, including high-definition endoscopy. High-definition endoscopes had a higher rate of neoplasia detection, but the significance was lost after adjustment for confounders, including chromoendoscopy (OR 1.93, 95% CI 0.69–5.40, P=0.21).
Conclusions
Chromoendoscopy is associated with a higher detection rate for neoplasia in patients with primary sclerosing cholangitis and IBD even with high-definition colonoscopes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Translational Gastroenterology and Liver Unit, Experimental Medicine Division, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom of Great Britain and Northern Ireland.
- Department of Gastroenterology, North Bristol NHS Trust, Bristol, United Kingdom of Great Britain and Northern Ireland.
- Department of Gastroenterology, St James's Hospital, Dublin, Ireland.
- Statistics, Statsconsultancy Ltd, Buckinghamshire, United Kingdom of Great Britain and Northern Ireland.
- Gastrointestinal Stem Cell Biology Lab, Wellcome Centre Human Genetics, University of Oxford, Oxford, United Kingdom of Great Britain and Northern Ireland.
- Translational Gastroenterology and Liver Unit, Nuffield Department of Medicine and, Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford…
Förderung
- Wellcome Trust
- NIHR Oxford Biomedical Research Centre
- Cancer Research UK
Zitieren
APA
Motta, R. V., Gupta, V., Hartery, K., Bassett, P., Leedham, S. J., Chapman, R. W., Travis, S. P., Culver, E. L., & East, J. E. (2024). Dye-based chromoendoscopy detects more neoplasia than white light endoscopy in patients with primary sclerosing cholangitis and IBD. Endoscopy International Open, 12(11), E1285-E1294. https://doi.org/10.1055/a-2437-8102
Vancouver
Motta RV, Gupta V, Hartery K, Bassett P, Leedham SJ, Chapman RW, et al. Dye-based chromoendoscopy detects more neoplasia than white light endoscopy in patients with primary sclerosing cholangitis and IBD. Endoscopy International Open. 2024;12(11):E1285-E1294. doi:10.1055/a-2437-8102
BibTeX
@article{Motta2024,
author = {Motta, Rodrigo V and Gupta, Vipin and Hartery, Karen and Bassett, Paul and Leedham, Simon J and Chapman, Roger W and Travis, Simon Pl and Culver, Emma L and East, James E},
title = {Dye-based chromoendoscopy detects more neoplasia than white light endoscopy in patients with primary sclerosing cholangitis and IBD},
journal = {Endoscopy International Open},
year = {2024},
volume = {12},
number = {11},
pages = {E1285--E1294},
doi = {10.1055/a-2437-8102}
}
EUVIMED